Skip to content

Clinical trials

Coronary Artery Disease trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Country / region: Hong Kong Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20122
20141
20161
20172
20183
20192
20203
20211
20222
20232
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting6
Unknown status3
Active, not recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The University of Hong Kong7
Chinese University of Hong Kong4
Abbott Medical Devices3
AstraZeneca2
Biotronik AG2
CSL Behring2
Fundación EPIC1
Medtronic1
Medtronic Vascular1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease26
Cardiovascular Diseases4
Atherosclerosis3
Coronary Stenosis3
Hemorrhagic Stroke3
Ischemic Stroke3
Myocardial Infarction3
Renal Insufficiency3
Stroke3
Acute Coronary Syndrome2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.